Leveraging Metrics and Market Factors for Portfolio Decision Making –
June 2008; Vol. 3 No. 3

While the trend to outsource key elements of drug development to service providers could slow down due in part to rising operating costs worldwide, drug developers need to adopt an outsourcing strategy that optimizes their skill sets.

“Companies need to keep in mind that one approach may not be appropriate for all development programs. Some may require a tactical approach, which is more ad hoc and project oriented, while others may benefit from a more formalized and portfolio oriented strategic approach.”